New

Global ETF Survey 2026: Answer now →

Help us improve your experience. Please confirm your investor type:

Compare ETFs Easily

The Ultimate ETF Comparison Tool - Try Now!

Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.

Advertisement
Advertisement
›Stocks›GILD

ETFs with exposure to Gilead Sciences, Inc. (GILD)

1,515 ETFs hold Gilead Sciences, Inc. (GILD)
Holdings data as of May 31, 2026
VanEck Biotech ETF - USD
This ETF provides exposure to US Biotechnology Equities
14.30%
+9.81%
+8.03%
-€55K
-€6.3M
€350M
0.35%
Invesco Nasdaq Biotechnology ETF - USD
This ETF provides exposure to US Equities
7.49%
+11.62%
+15.23%
-€814K
-€559K
€64M
0.19%
Not rated
iShares Biotechnology ETF - USD
This ETF provides exposure to US Biotechnology Equities
7.42%
+12.17%
+12.60%
+€348M
-€146M
€8.06B
0.44%
iShares Nasdaq US Biotechnology UCITS ETF (D) - USD
This ETF provides exposure to US Equities
Share class
Dist
USD
7.38%
+11.61%
+15.09%
+€269K
+€719K
€53M
0.35%
iShares Nasdaq US Biotechnology UCITS ETF - USD
This ETF provides exposure to US Equities
Share class
Acc
USD
7.38%
+11.61%
+15.09%
+€69M
+€32M
€884M
0.35%
Mirae Asset TIGER NASDAQ BIO ETF - KRW
This ETF provides exposure to US Equities
7.38%
+13.15%
+22.05%
-€2M
-€14M
€56M
0.3%
Not rated
CAPITAL NASDAQ BIOTECHNOLOGY INDEX ETF - TWD
This ETF provides exposure to US Equities
7.38%
+13.27%
+15.92%
€0
-€16K
€8.8M
1.01%
Not rated
Invesco NASDAQ Biotech UCITS ETF Acc - USD
This ETF provides exposure to US Equities
7.38%
+11.64%
+15.11%
+€14M
-€17M
€410M
0.4%
iShares Health Innovation Active ETF - USD
This ETF provides exposure to Other Equities
5.42%
+8.35%
+1.63%
€0
+€3.2M
€9.7M
0.77%
Not rated
BMO Covered Call Health Care ETF - CAD
This ETF provides exposure to Health Care Equities
5.07%
+7.79%
-0.69%
+€2.4M
+€7.4M
€24M
0.73%
Not rated
See more results with a Trackinsight account
Get started with a free Essentials account today.
Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight